Overview
Mae'r cynnwys hwn ar gael yn Saesneg yn unig.
This conference is organised by imaging and clinical dementia scientists from the Universities of Cardiff, Bristol, Bath and Cambridge and focuses on the role of MRI in risk identification, early diagnosis and clinical trials.
The conference programme will include presentations about the latest developments in MR technologies, including white matter imaging, and their applications to dementia research. Whilst a number of key speakers have already been confirmed, we also encourage junior scientists to submit their work for presentation.
The conference is supported by the Guarantors of Brain, Alzheimer's Society and Alzheimer's Research UK.
Conference objectives
- To present the state-of-the-art MRI techniques and their role in dementia diagnosis and treatment monitoring
- To communicate/present novel MRI techniques that allow imaging of white matter microstructure and highlight the utility of these techniques in detection of early dementia pathology
- To communicate clinical MRI findings from white matter pathology in early dementia
- To communicate potentials of advanced MRI to detect genetic biomarkers in imminent dementia
- To communicate work on MRI dementia biomarker search
- To communicate recent use of MRI biomarkers in drug discovery and drug trials.
Organisers
Claudia Metzler-Baddeley (Cardiff University, Chair)
Richard Wise (Cardiff University)
Risto Kauppinen (University of Bristol)
Elizabeth Coulthard (University of Bristol)
Roy Jones (University of Bath)
Julian Hughes (University of Bristol)
Dennis Chan (University of Cambridge)
Learn about our history, our strategy, our values and the capital city in which we are located.